Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows
Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...
New Atlas18h
Researchers find cancer's 'off-grid' power supply – and how to cut it
Researchers have discovered a particular type of cancer cell that relies on its own biological electric utility company to thrive. Disrupting this power plant – with the help of a puffer fish – showed ...
Pastor Walter Womack, president of Memphis SCLC, has died
Pastor Walter Womack, president of the Memphis Southern Christian Leadership Conference (SCLC), has died, according to ...
FOX13 Memphis1d
Community faith leader Rev. Walter Womack dies , Memphis NAACP branch says
A prominent Memphis community faith leader, Rev. Walter Womack, died on Wednesday, the Memphis branch of the National ...
The American Journal of Managed Care13d
5 Potential Therapeutic Targets for Small Cell Lung Cancer
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
The Rogersville Review5h
Black History Month: The Fight for Economic Justice
The Poor People’s Campaign, conceived by Dr. Martin Luther King Jr. and the Southern Christian Leadership Conference (SCLC) ...
The American Journal of Managed Care6d
Study Finds Declining SCLC Incidence, but Stagnant Survival Rates
SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more ...
Targeted Oncology6d
FDA Grants 225Ac-SSO110 Orphan Drug Status in SCLC
Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
Business Wire22d
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
“Receiving an Orphan Drug Designation for ZL-1310 recognizes its potential to treat patients with SCLC. These patients have an urgent need for innovative treatment options with improved ...
Morningstar8d
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab was granted orphan drug designations by the FDA and the EC for the treatment of SCLC, and its bridging head-to-head trial in the United States to compare HANSIZHUANG to standard of ...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...